Top DOJ Civil Fraud Official Joins Akin Gump, Highlighting Trend of Public-to-Private Sector Shifts

In the latest shift within Washington’s legal landscape, the Department of Justice’s renowned civil fraud official has transitioned to Akin, Gump, Strauss, Hauer & Feld LLP’s prestigious Washington office. This move is especially significant as it reflects ongoing trends of experienced public servants moving into private practice, aligning closely with the aims of prominent legal…

Read More

Brazil Receives UN Accolade for Humanitarian Migration Policies, Urged to Enhance Implementation

The United Nations has recognized Brazil for its commendable legal framework regarding the treatment of migrants, refugees, and asylum seekers. Highlighting the country’s migration policies, the UN special rapporteur on the human rights of migrants, Gehad Madi, praised Brazil for offering robust protections that guarantee fundamental human rights irrespective of nationality. The announcement followed Madi’s…

Read More

Inspired Healthcare Faces Turmoil Over Potential Raymond James Advisory Amidst Scrutiny

Inspired Healthcare’s decision to potentially engage financial advisory services from Raymond James has sparked considerable resistance from various stakeholders. This unfolding situation highlights the intricacies and challenges corporations face when enlisting advisory firms, especially when the advisory firm’s historical dealings come under scrutiny. According to details shared by Bloomberg Law, the controversy arose when Inspired…

Read More

Supreme Court Sends Colorado’s ‘Conversion Therapy’ Ban Case Back for Further Review, Citing Free Speech Concerns

The U.S. Supreme Court has remitted a significant case concerning Colorado’s ban on “conversion therapy” back to the lower courts for reevaluation. The 8-1 decision favors Kaley Chiles, a therapist who claimed the law infringes on her right to free speech, particularly her ability to express certain views during therapy sessions with minors. This legal…

Read More

U.S. Supreme Court Urged to Uphold Lower Court Ruling in Crucial Patent Dispute Over Generic Drugs

In a significant legal battle, drugmakers, industry groups, hospitals, and scholars have collectively urged the U.S. Supreme Court to maintain a lower court’s decision that allows a patent lawsuit to continue concerning a generic drug utilizing a “skinny label.” This appeal highlights the industry’s resistance to granting generic drug companies special protections that could disrupt…

Read More

New York Judge Upholds $70 Million Verdict in TriZetto-Syntel Trade Secret Dispute, Highlights Importance of Intellectual Property Protection

In a significant judicial ruling, a New York federal judge has maintained a $70 million compensatory damages verdict awarded to the TriZetto Group, a healthcare IT solutions provider, in its trade secrets litigation against Syntel Inc. This decision comes after a protracted legal battle over the misappropriation of intellectual property relevant to health insurance technology…

Read More

Delaware Court Upholds $34 Million Verdict Against Alcon in Sight Sciences Patent Dispute

In a recent decision, a Delaware federal judge has upheld a $34 million verdict in a patent infringement case involving Alcon. The case centered around allegations that Alcon and its affiliated entities infringed on patents held by Sight Sciences Inc. These patents pertain to medical devices designed for the treatment of glaucoma. This verdict confirmation…

Read More

Nixon Peabody Bolsters Litigation Practice with Expert Partner in Providence Office Expansion

Nixon Peabody has taken a significant step in enhancing its litigation capabilities by welcoming a seasoned disputes partner to its Providence office. This move is part of the firm’s strategic commitment to bolstering its complex litigation practice, particularly in the New England region. The new partner, who brings extensive experience in handling intricate commercial disputes,…

Read More

Bracewell LLP Enhances Appellate Litigation with Recruitment of Renowned Partner Jeremy Siegal

In a move that underscores the competitive atmosphere among law firms in Washington, D.C., Bracewell LLP has announced the recruitment of Jeremy Siegal, a distinguished appellate partner from Norton Rose Fulbright. This strategic acquisition is set to enhance Bracewell’s appellate litigation capabilities as they continue to expand their footprint in high-stakes legal arenas. Jeremy Siegal,…

Read More

Federal Judge Allows Key Elements of Eli Lilly’s Lawsuit Against Telehealth Firms to Proceed

A legal battle involving Eli Lilly over its obesity and type 2 diabetes drugs has taken a significant turn as a federal judge in California decided to let most of the lawsuit proceed. The case, focusing on allegations against two telehealth companies accused of replicating Eli Lilly’s medications, challenges the boundaries of pharmaceutical patent protection…

Read More

Judge Dismisses Abbott Labs Lawsuit Over Infant Formula, Highlighting Liability Issues in Healthcare Products

A recent decision by Broward County Circuit Judge Carol-Lisa Phillips has led to the dismissal of a high-profile lawsuit against Abbott Laboratories, originally slated for trial next month. The case revolved around allegations from Tiana Ennix, whose premature daughter, Iyiana, developed necrotizing enterocolitis (NEC) after consuming Abbott’s Similac Special Care formula. Judge Phillips determined that…

Read More

David J. Karp Joins Polsinelli’s New York Office, Strengthening Real Estate Investment Practice

Polsinelli, a law firm recognized for its breadth across varied practice areas, has announced the addition of David J. Karp as a shareholder in its New York office. This strategic hire is aimed at fortifying the firm’s real estate investment sector, where Karp brings significant expertise. As reported by Bloomberg Law, Karp is expected to…

Read More

McKesson Lawsuit Highlights Growing Concerns Over Trade Secret Protection in Employee Mobility Cases

In a significant legal dispute, McKesson Corp., a key player in the healthcare services industry, has initiated legal action against a former senior executive. Filed in a Colorado federal district court, the lawsuit alleges that the executive has breached her contractual obligations by disclosing McKesson’s confidential information and trade secrets to a direct competitor shortly…

Read More

Legislative Update Strengthens Orphan Drug Act, Boosts Innovation for Rare Disease Treatments

In February 2026, the pharmaceutical industry witnessed a legislative development with the enactment of the 2026 Consolidated Appropriations Act. This new law addresses longstanding issues within the Orphan Drug Act, providing clarity and incentives for companies engaged in the research and development of orphan drugs, which are crucial for treating rare diseases. This legislative update…

Read More

New York AG Reaches $2.5 Million Settlement with EmblemHealth Over Misleading Mental Health Provider Networks

New York Attorney General Letitia James has announced a $2.5 million settlement with EmblemHealth, focusing on allegations that the insurer misrepresented its network of mental health providers. This situation sheds light on the pervasive issue of “ghost networks,” wherein healthcare plans list providers who are, in reality, unavailable. The agreement with EmblemHealth is part of…

Read More

Senate Confirms Colin McDonald to Lead DOJ’s New Fraud Division Amid Rising National Focus on Economic Crimes

The U.S. Senate has confirmed Colin McDonald as the Assistant Attorney General for the newly established Fraud Division within the Department of Justice. This move, decided by a narrow 52-47 vote along party lines, marks a significant step in the Biden administration’s efforts to address complex fraud cases that have surged in recent years. The…

Read More

QuidelOrtho Appoints New Chief Legal Officer to Navigate Complex Global Regulatory Landscape

QuidelOrtho Corp, a prominent entity in the in vitro diagnostics sector, has recently appointed a new Chief Legal Officer. Timothy J. Guertin steps into this pivotal role, bringing with him a wealth of experience in corporate legal affairs. His appointment comes as QuidelOrtho continues to strengthen its position in the global diagnostics market, which has…

Read More

Federal Anti-Fraud Task Force to Intensify Scrutiny on Healthcare Compliance and False Claims法规

A newly established federal anti-fraud task force promises to intensify scrutiny on state and local governments, contractors, and companies, particularly within healthcare fraud and False Claims Act cases. This initiative, comprising more than a dozen federal agencies, highlights evolving challenges for businesses navigating compliance risks and marks a pivotal moment for firms specializing in white-collar…

Read More

Vincent Schmeltz Joins Steptoe & Johnson LLP as Partner to Strengthen Chicago White-Collar Practice

Vincent Schmeltz has joined Steptoe & Johnson LLP as a partner in their Chicago office, where he will focus on investigations and white-collar defense. This move expands Steptoe’s capabilities in handling complex regulatory and investigative challenges across a spectrum of industries. Bloomberg Law notes that Schmeltz’s addition is aimed at bolstering the firm’s national regulatory…

Read More

Delaware Court of Chancery’s Recent Cases Highlight Influence on Corporate Law and Governance

The Delaware Court of Chancery, known for its pivotal role in shaping corporate law, recently tackled several significant cases that caught the legal community’s attention. This past week, the court’s docket included high-stakes disputes involving major consumer brands, the reinstatement of a video game executive, the ongoing discourse around noncompete agreements, and emerging allegations of…

Read More

Amarin Pharma Urges Supreme Court to Uphold Vascepa Patent Ruling, Sparking Industry-Wide Patent Law Debate

Amarin Pharma Inc. has petitioned the U.S. Supreme Court to maintain a ruling supporting its claim that Hikma Pharmaceuticals USA Inc. has actively encouraged infringement upon its patents for the heart drug Vascepa. This legal battle, with significant implications for intellectual property rights, emphasizes the potential nationwide impact of a reversal. Amarin argues that such…

Read More

WHO Condemns Attack on Sudan Hospital Amid Intensifying Conflict and Humanitarian Crisis

The World Health Organization (WHO) has denounced a devastating attack on Al Deain Teaching Hospital in Sudan, which resulted in significant casualties. On March 20, the assault claimed the lives of over 64 people, including 13 children, healthcare workers, and patients. Eighty-nine individuals were injured, while critical damage to the hospital’s pediatric, maternity, and emergency…

Read More